Financials

News Discussions Technicals Forecast Seasonals

Total revenue of Verve Therapeutics, Inc.

Annual data

2020

2021

2022

2023

2024

TTM

‪0.00‬

‪‪9.00 M‬‬

‪‪18.00 M‬‬

‪‪27.00 M‬‬

‪‪36.00 M‬‬

Period

Value

Change

Change %

TTM

‪‪32.33 M‬‬

‪0.00‬

‪0.00‬%

2024

‪‪32.33 M‬‬

+‪‪20.57 M‬‬

+‪174.98‬%

2023

‪‪11.76 M‬‬

+‪‪9.82 M‬‬

+‪505.77‬%

2022

‪‪1.94 M‬‬

+‪‪1.94 M‬‬

—

2021

‪0.00‬

‪0.00‬

—

2020

‪0.00‬

‪0.00‬

—

Quarterly data

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0.00‬

‪‪3.50 M‬‬

‪‪7.00 M‬‬

‪‪10.50 M‬‬

‪‪14.00 M‬‬

Period

Value

Change

Change %

Q4 '24

‪‪13.08 M‬‬

+‪‪6.21 M‬‬

+‪90.53‬%

Q3 '24

‪‪6.87 M‬‬

+‪‪173.00 K‬‬

+‪2.59‬%

Q2 '24

‪‪6.69 M‬‬

+‪‪997.00 K‬‬

+‪17.51‬%

Q1 '24

‪‪5.70 M‬‬

+‪‪551.00 K‬‬

+‪10.71‬%

Q4 '23

‪‪5.14 M‬‬

+‪‪2.03 M‬‬

+‪65.03‬%

Q3 '23

‪‪3.12 M‬‬

+‪‪1.02 M‬‬

+‪48.92‬%

Q2 '23

‪‪2.09 M‬‬

+‪‪689.00 K‬‬

+‪49.07‬%

Q1 '23

‪‪1.40 M‬‬

+‪‪392.00 K‬‬

+‪38.74‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20